Publikationen aus den Kliniken

Hier finden Sie eine Übersicht der Abteilungen, in denen Forschung und Publikation Teil der täglichen Arbeit sind.

Allgemeinchirurgie, Viszeralchirurgie, Thoraxchirurgie und Gefäßchirurgie

Prof. Dr. med. Matthias Reeh, Chefarzt
Zu den Publikationen

Diagnostische und Interventionelle Radiologie

Prof. Dr. med. Christian R. Habermann, Chefarzt
Zu den Publikationen
Dr. med. Nando Mertineit, Leitender Oberarzt
Zu den Publikationen

Gynäkologie

Assoc. Prof. Ahmed Farouk Abdelkawi EG, Chefarzt
Zu den Publikationen

HNO-Heilkunde

Prof. Dr. med. Adrian Münscher, Chefarzt
  1. Busch CJ, Hagel C, Becker B, Oetting A, Möckelmann N, Droste C, Möller-Koop C, Witt M, Blaurock M, Loges S, Rothkamm K, Betz C, Münscher A, Clauditz TS, Rieckmann T. Tissue Microarray Analyses Suggest Axl as a Predictive Biomarker in HPV-Negative Head and Neck Cancer. Cancers (Basel). 2022 Apr 5; 14(7):1829. doi: 10.3390/cancers14071829. PMID: 35406601; PMCID: PMC8997923.
  2. Falz H, von Lücken HJ, Münscher A, Möckelmann N. A comparative study of BiZact™ tonsillectomy versus cold steel dissection technique in adults: Analysis of operating time, intraoperative blood loss, postoperative bleeding rate and pain. Clin Otolaryngol. 2024 May; 49(3):299-305. doi: 10.1111/coa.14140. Epub 2024 Jan 2. PMID: 38169104.
  3. Flockerzi V, Schick B. German Acoustic Fireworks-associated Traumata Study (GAFATS) Group; Bozzato A. Thunder and lightning – a report on firework-associated acoustic trauma at New Year 2021/2022. HNO. 2023 Aug; 71(Suppl 1): 44-49. doi: 10.1007/s00106-022-01260-z. Epub 2023 Feb 27. PMID: 36847786; PMCID: PMC9969936.
  4. Flockerzi V, Schick B German Acoustic Fireworks-associated Traumata Study (GAFATS) Group; Bozzato A. Schlag auf Schlag – Bericht über feuerwerksbedingte Knalltraumata zum Jahreswechsel 2021/2022 [Thunder and lightning – a report on firework-associated acoustic trauma at New Year 2021/2022 (German version)]. HNO. 2023 Jan; 71(1):1-7. German. doi: 10.1007/s00106-022-01259-6. Epub 2023 Jan 5. PMID: 36602581; PMCID: PMC9815053.
  5. Borgmann M, Oetting A, Meyer F, Möckelmann N, Droste C, von Bargen CM, Möller-Koop C, Witt M, Borgmann K, Rothkamm K, Betz C, Münscher A, Clauditz TS, Rieckmann T. The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma. J Cancer Res Clin Oncol. 2023 Jul; 149(7):3383-3393. doi: 10.1007/s00432-022-04244-2. Epub 2022 Aug 8. PMID: 35941227; PMCID: PMC10314856.
  6. Berger J, Zech HB, Hoffer K, von Bargen CM, Nordquist L, Bussmann L, Gatzemeier F, Busch CJ, Möckelmann N, Münscher A, Betz CS, Petersen C, Rothkamm K, Rieckmann T, Köcher S, Kriegs M. Kinomic comparison of snap frozen and ex vivo-cultured head and neck tumors. Oral Oncol. 2021 Dec;123:105603. doi: 10.1016/j.oraloncology.2021.105603. Epub 2021 Nov 16. PMID: 34798574.
  7. Wurlitzer M, Möckelmann N, Kriegs M, Vens M, Omidi M, Hoffer K, Bargen CV, Möller-Koop C, Witt M, Droste C, Oetting A, Petersen H, Busch CJ, Münscher A, Schlüter H, Clauditz TS, Rieckmann T. Mass Spectrometric Comparison of HPV- Positive and HPV-Negative Oropharyngeal Cancer. Cancers (Basel). 2020 Jun 11; 12(6):1531. doi: 10.3390/cancers12061531. PMID: 32545200; PMCID: PMC7352546.
  8. Böttcher A, Betz CS, Bartels S, Schoennagel B, Münscher A, Bußmann L, Busch CJ, Knopke S, Bibiza E, Möckelmann N. Rational surgical neck management in total laryngectomy for advanced stage laryngeal squamous cell carcinomas. J Cancer Res Clin Oncol. 2021 Feb; 147(2):549-559. doi: 10.1007/s00432-020-03352-1. Epub 2020 Aug 18. PMID: 32809056; PMCID: PMC7817600.
  9. Bußmann L, Hoffer K, von Bargen CM, Droste C, Lange T, Kemmling J, Schröder-Schwarz J, Vu AT, Akingunsade L, Nollau P, Rangarajan S, de Wijn R, Oetting A, Müller C, Böckelmann LC, Zech HB, Berger JC, Möckelmann N, Busch CJ, Böttcher A, Gatzemeier F, Klinghammer K, Simnica D, Binder M, Struve N, Rieckmann T, Schumacher U, Clauditz TS, Betz CS, Petersen C, Rothkamm K, Münscher A, Kriegs M. Analyzing tyrosine kinase activity in head and neck cancer by functional kinomics: Identification of hyperactivated Src family kinases as prognostic markers and potential targets. Int J Cancer. 2021 Sep 1; 149(5):1166-1180. doi: 10.1002/ijc.33606. Epub 2021 May 7. Erratum in: Int J Cancer. 2022 May 15; 150(10):E6. doi: 10.1002/ijc.33961. PMID: 33890294.
  10. Zech HB, von Bargen C, Oetting A, Möckelmann N, Möller-Koop C, Witt M, Struve N, Petersen C, Betz C, Rothkamm K, Münscher A, Clauditz TS, Rieckmann T. Tissue microarray analyses of the essential DNA repair factors ATM, DNA-PKcs and Ku80 in head and neck squamous cell carcinoma. Radiat Oncol. 2024 Oct 30; 19(1):150. doi: 10.1186/s13014-024-02541-3. PMID: 39478631; PMCID: PMC11523811.
  11. Bold IT, Specht AK, Droste CF, Zielinski A, Meyer F, Clauditz TS, Münscher A, Werner S, Rothkamm K, Petersen C, Borgmann K. DNA Damage Response during Replication Correlates with CIN70 Score and Determines Survival in HNSCC Patients. Cancers (Basel). 2021 Mar 10; 13(6):1194. doi: 10.3390/cancers13061194. PMID: 33801877; PMCID: PMC7998578.
  12. Loeck J, von Lücken HJ, Münscher A, Müller CT, Loske G. Endoscopic negative pressure therapy (ENPT) in head and neck surgery: first experiences in treatment of postoperative salivary fistulas and cervical esophageal perforations. Eur Arch Otorhinolaryngol. 2021 Nov; 278(11):4525-4534. doi: 10.1007/s00405-021-06709-5. Epub 2021 Mar 14. PMID: 33715018.
  13. Autorinnen/Autoren; Collaborators. Das multizentrische Register „Oropharynxkarzinom“ des Deutschen Studienzentrums für HNO – erste Ergebnisse [The multicenter registry „oropharyngeal cancer“ of the German ENT Study Center – First Results]. Laryngorhinootologie. 2024 Aug 21. German. doi: 10.1055/a-2374-2310. Epub ahead of print. Erratum in: Laryngorhinootologie. 2024 Sep 02. doi: 10.1055/a-2404-2934. PMID: 39168130. Prof. Dr. med. Adrian Münscher
PD Dr. med. Nikolaus Möckelmann, Oberarzt
  1. Tissue microarray analyses of the essential DNA repair factors ATM, DNA-PKcs and Ku80 in head and neck squamous cell carcinoma. Zech HB, von Bargen C, Oetting A, Möckelmann N, Möller-Koop C, Witt M, Struve N, Petersen C, Betz C, Rothkamm K, Münscher A, Clauditz TS, Rieckmann T. Radiat Oncol. 2024 Oct 30;19(1):150. doi: 10.1186/s13014-024-02541-3.
  2. The multicenter registry „oropharyngeal cancer“ of the German ENT Study Center -First Results.Dirk Beutner, Nicholas Bevis, Carlotta Derad , Thomas Asendorf, Ralf Tostmann, Heinrich Iro, Jens Peter Klußmann , Orlando Guntinas-Lichius, Stephan Hackenberg, Thomas Gehrke, Nikolaus Möckelmann, Adrian Münscher, Omar Almajali, Christopher Bohr, Julian Künzel, Jannik Johannsen, Jan Maurer, Hartmut Stoll, Dirk Korbmacher-Roschkowski, Jörg Ebmeyer, Nicole Rotter, Annette Affolter, Antoniu-Oreste Gostian, Elisabeth Wimmer, Cornelius Kürten, A Daser, Mussab Kouka, Hanna Obermeier, Victoria Hackl, Luca Engelmann, Benedikt Schmidl, Julia Asendorf, Andreas Otto Heinrich Gerstner, Amir Minovi, Klaus Scheuermann, K-Wolfgang Delank, Alexander Hafften, Sebastian Putz, Laura Marie Sommer, Maximilian Traxdorf, Martin Wilhelm, Chia-Jung Busch, Ariane Renson, Maximilian Linxweiler, Alessandro Bozzato, Ulrike Bockmühl, Sonja Weiß, Ali Eric Chaaban, Wolfgang Nehler, Omid Majdani, Henrike Zech, Jacob Clausen, Georges Majerus, Georges Joseph, Anke Becker, Markus Jungehülsing, Carolin Beck, Lara Vogel, Lena Cohrs, Daniel Steller, Oliver Reichel, Martin Sailer, Jonas J-H Park, Inga M C Seuthe, Julian Kreusel, Lukas Bachmann, Zoltán Trojnar, Gunnar Doobe. Laryngorhinootologie. 2024 Aug 21. doi: 10.1055/a-2374-2310.
  3. A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts, NIHR Global Health Research Unit on Global Surgery; STARSurg Collaborative. Lancet Digit Health. 2024 Jul;6(7):e507-e519. doi: 10.1016/S2589-7500(24)00065-7.
  4. Tumor-stroma ratio in preoperative biopsies and matched surgical specimens in oral squamous cell carcinoma: Concordance and impact on recurrence-free and overall survival Knief J, Herber K, Muenscher A, Thorns C, Moeckelmann N. Pathol Res Pract. 2024 Mar:255:155211. doi: 10.1016/j.prp.2024.155211.
  5. A comparative study of BiZact™ tonsillectomy versus cold steel dissection technique in adults: Analysis of operating time, intraoperative blood loss, postoperative bleeding rate and pain. Falz H, von Lücken HJ, Münscher A, Möckelmann N. Clin Otolaryngol. 2024 Jan 2. doi: 10.1111/coa.14140.
  6. Outcomes following oropharyngeal squamous cell carcinoma resection and bilateral neck dissection with or without contralateral postoperative radiotherapy of the pathologically node-negative neck. Jansen F, Betz CS, Belau MH, Matnjani G, Clauditz TS, Dwertmann-Rico S, Stölzel K, Möckelmann N, Böttcher A. Eur Arch Otorhinolaryngol. 2023 Aug;280(8):3843-3853
  7. The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma. Borgmann M, Oetting A, Meyer F, Möckelmann N, Droste C, von Bargen CM, Möller-Koop C, Witt M, Borgmann K, Rothkamm K, Betz C, Münscher A, Clauditz TS, Rieckmann T. J Cancer Res Clin Oncol. 2023 Jul;149(7):3383-3393.
  8. A Four-Generational Report on Hereditary Head and Neck Paraganglioma. Trache MC, Bewarder J, Betz CS, Möckelmann N, Böttcher A. Cureus. 2022 Apr 14;14(4):e24143.
  9. Tissue Microarray Analyses Suggest Axl as a Predictive Biomarker in HPV-Negative Head and Neck Cancer. Busch CJ, Hagel C, Becker B, Oetting A, Möckelmann N, Droste C, Möller-Koop C, Witt M, Blaurock M, Loges S, Rothkamm K, Betz C, Münscher A, Clauditz TS, Rieckmann T. Cancers (Basel). 2022 Apr 5;14(7):1829.
  10. Patient derived ex vivo tissue slice cultures demonstrate a profound DNA double-strand break repair defect in HPV-positive oropharyngeal head and neck cancer. Zech, H, Berger, J, Mansour W, Nordquis L, von Bargen C, Bußmann L, Oetting A, Christiansen S, Möckelmann N, Böttcher A, Busch C-J, Petersen C, Betz C, Rothkamm K, Kriegs M, Köcher S, Rieckmann T. Radiother Oncol, 2022. 168: p. 138-146.
  11. Tissue Microarray Analyses Suggest Axl as a Predictive Biomarker in HPV-Negative Head and Neck Cancer. Busch, C.J., Hagel, C, Becker, B, Oetting, A, Möckelmann, N, Droste, C, Möller-Koop, C, Witt, M, Blaurock, M, Loges, S, Rothkamm, K, Betz, C, Münscher, A, Clauditz, T, Rieckmann, T. Cancers (Basel), 2022. 14(7).
  12. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. COVIDSurg Collaborative. Anaesthesia, 2022. 77(1): p. 28-39.
  13. Analyzing tyrosine kinase activity in head and neck cancer by functional kinomics: Identification of hyperactivated Src family kinases as prognostic markers and potential targets. Bußmann L, Hoffer K, von Bargen C, Droste C, Lange T, Kemmling J, Schröder-Schwarz J, Vu A, Akingunsade L, Nollau P, Rangarajan S, de Wijn R, Oetting A, Müller C, Böckelmann L, Zech H, Berger J, Möckelmann N, Busch C-J, Böttcher A, Gatzemeier F, Klinghammer K, Simnica D, Binder M, Struve N, Rieckmann T, Schumacher U, Clauditz T, Betz C, Petersen C, Rothkamm K, Münscher A, Kriegs M. Int J Cancer, 2021. 149(5): p. 1166-1180.
  14. Kinomic comparison of snap frozen and ex vivo-cultured head and neck tumors. Berger J, Zech H, Hoffer K, von Bargen C, Nordquist L, Bußmann L, Gatzemeier F, Busch C-J, Möckelmann N, Münscher A, Betz C, Petersen C, Rothkamm K, Rieckmann T, Köcher S, Kriegs M. Oral Oncol, 2021. 123: p. 105603.
  15. Global wealth disparities drive adherence to COVID-safe pathways in head and neck cancer surgery. COVIDSurg Collaborative. BJS Open, 2021. 5(6).
  16. Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score. COVIDSurg Collaborative. Br J Surg, 2021. 108(11): p. 1274-1292.
  17. Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic. COVIDSurg Collaborative. Br J Surg, 2021. 108(12): p. 1448-1464.
  18. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. COVIDSurg Collaborative. Lancet Oncol, 2021. 22(11): p. 1507-1517.
  19. A rare tumor manifestation in the head and neck region. Jansen, F, Möckelmann, N, Böttcher, A. Hno, 2021.
  20. Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study. COVIDSurg Collaborative. Anaesthesia, 2021. 76(11): p. 1454-1464.
  21. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study. COVIDSurg Collaborative. Br J Surg, 2021. 108(9): p. 1056-1063.
  22. Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic. COVIDSurg Collaborative. Br J Surg, 2021. 108(1): p. 88-96.
  23. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. COVIDSurg Collaborative. Anaesthesia, 2021. 76(6): p. 748-758.
  24. Head and neck cancer surgery during the COVID-19 pandemic: An international, multicenter, observational cohort study.“ COVIDSurg Collaborative, Cancer, 2021 Jul 15;127(14):2476-2488
  25. Rational surgical neck management in total laryngectomy for advanced stage laryngeal squamous cell carcinomas. Böttcher A, Betz CS, Bartels S, Schoennagel B, Münscher A, Bußmann L, Busch CJ, Knopke S, Bibiza E, Möckelmann N. J Cancer Res Clin Oncol. 2021 Feb;147(2):549-559.
  26. Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study. COVIDSurg Collaborative. J Clin Oncol. 2021 Jan 1;39(1):66-78.
  27. Phase III study of nivolumab alone or combined with ipilimumab as immunotherapy versus standard of care in resectable head and neck squamous cell carcinoma. Zech HB, Moeckelmann N, Boettcher A, Muenscher A, Binder M, Vettorazzi E, Bokemeyer C, Schafhausen P, Betz CS, Busch CJ. Future Oncol. 2020 Dec;16(36):3035-3043
  28. Delaying surgery for patients with a previous SARS-CoV-2 infection. COVIDSurg Collaborative. Br J Surg. 2020 Nov;107(12): e601-e602.
  29. Comparative effectiveness trial of transoral head and neck surgery followed by adjuvant radio(chemo)therapy versus primary radiochemotherapy for oropharyngeal cancer (TopROC). Bußmann L, Laban S, Wittekindt C, Stromberger C, Tribius S, Möckelmann N, Böttcher A, Betz CS, Klussmann JP, Budach V, Muenscher A, Busch CJ.BMC Cancer. 2020 Jul 29;20(1):701.
  30. Mass Spectrometric Comparison of HPV-Positive and HPV-Negative Oropharyngeal Cancer. Wurlitzer, M., Möckelmann, N., Kriegs, M., Vens, M., Omidi, M., Hoffer, K., von Bargen, C., Möller-Koop, C., Witt, M., Droste, C., Oetting, A., Petersen, H., Busch, C., Münscher, A., Schlüter, H., Clauditz, T., Rieckmann, T. Cancers 2020, 12(6), 1531
  31. Receptor tyrosine kinase MET as potential target of multi-kinase inhibitor and radiosensitizer sorafenib in HNSCC. Beizaei, K., Gleißner, L., Hoffer, K., Bußmann, L., Steinmeister, L., Laban, S., Möckelmann, N., Münscher, A., Petersen, C., Rothkamm, K., Kriegs, M., Head Neck. 2019 Jan;41(1):208-215.
  32. New aspects in thyroid cancer treatment: Highlights of the ASCO Annual Meeting 2019. N. Möckelmann, C. Betz. HNO. 2019
  33. Prognostic implications of the 8th Edition American Joint Committee on Cancer (AJCC) Staging System in oral cavity squamous cell carcinoma. Möckelmann, N., Ebrahimi, A., Tou, Y., Gupta, R., Low, T., Ashford, B., Ch’ng, S., Palme, C., Clark, J. Oral Oncol. 2018 Oct; 85:82-86.
  34. Analysis and Comparison of the 8th Edition American Joint Committee on Cancer (AJCC) Nodal Staging System in Cutaneous and Oral Squamous Cell Cancer of the Head and Neck. Möckelmann, N., A. Ebrahimi, R. Dirven, J. Liu, T. H. Low, R. Gupta, B. Ashford, S. Ch’ng, C. E. Palme, and J. R. Clark. Ann Surg Oncol. 2018 Jun; 25(6):1730-1736.
  35. New aspects in thyroid cancer treatment: Highlights of the ASCO Annual Meeting 2018. N. Möckelmann, A. Münscher. HNO. 2018 Dec; 66(12):896-900.
  36. Expression of Epithelial-Mesenchymal Transition Regulating Transcription Factors in Head and Neck Squamous Cell Carcinomas. Goppel, J., N. Möckelmann, A. Muenscher, G. Sauter, and U. Schumacher. Anticancer Res 37, no. 10 (Oct 2017): 5435-40.
  37. Tumor Thickness Versus Depth of Invasion – Analysis of the 8th Edition American Joint Committee on Cancer Staging for Oral Cancer. Dirven, R., A. Ebrahimi, N. Möckelmann, C. E. Palme, R. Gupta, and J. Clark. Oral Oncol 74 (Nov 2017): 30-33.
  38. New Aspects in the Treatment of Thyroid Cancer: Highlights of the Asco Annual Meeting 2016. Lorincz, B. B., C. Simon, N. Möckelmann, and R. Knecht. Hno 64, no. 10 (Oct 2016): 736-40.
  39. Effect of Sorafenib on Cisplatin-Based Chemoradiation in Head and Neck Cancer Cells. Möckelmann, N., T. Rieckmann, C. J. Busch, B. Becker, L. Gleissner, K. Hoffer, M. Omniczynski, L. Steinmeister, S. Laban, R. Grenman, C. Petersen, K. Rothkamm, E. Dikomey, R. Knecht, and M. Kriegs. Oncotarget (Mar 22 2016). http://dx.doi.org/10.18632/oncotarget.8275.
  40. The Impact of Surgical Technique on Neck Dissection Nodal Yield: Making a Difference. Loerincz, B. B., F. Langwieder, N. Möckelmann, S. Sehner, and R. Knecht. Eur Arch Otorhinolaryngol 273, no. 5 (May 2016): 1261-7.
  41. Palliative Treatment Standards for Head and Neck Squamous Cell Carcinoma: Survey of Clinical Routine in German-Speaking Countries. Laban, S., J. Kimmeyer, R. Knecht, T. K. Hoffmann, C. J. Busch, J. A. Veit, N. Möckelmann, and T. Kurzweg. Hno 64, no. 7 (Jul 2016): 487-93.
  42. Oncologic Treatment Landscape for Head and Neck Squamous Cell Carcinoma: Treatment Infrastructure in German-Speaking Countries. Kimmeyer, J., T. Kurzweg, T. K. Hoffmann, R. Knecht, J. A. Veit, N. Möckelmann, A. Munscher, and S. Laban. Hno 64, no. 7 (Jul 2016): 494-500.
  43. Similar Cisplatin Sensitivity of Hpv-Positive and -Negative Hnscc Cell Lines. Busch, C. J., B. Becker, M. Kriegs, F. Gatzemeier, K. Krueger, N. Möckelmann, G. Fritz, C. Petersen, R. Knecht, K. Rothkamm, and T. Rieckmann. Oncotarget (Apr 26 2016).
  44. Automatic Periodic Stimulation of the Vagus Nerve During Single-Incision Transaxillary Robotic Thyroidectomy: Feasibility, Safety, and First Cases. Loerincz, B. B., N. Möckelmann, C. J. Busch, M. Hezel, and R. Knecht. Head Neck 38, no. 3 (Mar 2016): 482-5.
  45. Is (Chemo)Radiotherapy Really the Future Standard in the Treatment of Oropharyngeal Carcinoma? Knecht, R., L. Bussmann, N. Möckelmann, and B. B. Lorincz. Hno 64, no. 4 (Apr 2016): 221-6.
  46. Robotic-Assisted Selective and Modified Radical Neck Dissection in Head and Neck Cancer Patients. Möckelmann, N., B. B. Lorincz, and R. Knecht. Int J Surg 25 (Jan 2016): 24-30.
  47. Role of Panendoscopy in Identifying and Managing Risk of Head and Neck Squamous Cell Carcinoma in Routine Follow-Up: A Retrospective Clinical Evaluation. Muenscher, A., S. Sehner, J. Taleh, S. Tribius, N. Möckelmann, A. Boettcher, A. Gulati, C. Dalchow, T. Clauditz, and R. Knecht. Eur Arch Otorhinolaryngol 272, no. 7 (Jul 2015): 1769-75.
  48. Timing of Neck Dissection in Patients Undergoing Transoral Robotic Surgery for Head and Neck Cancer. Möckelmann, N., C. J. Busch, A. Muenscher, R. Knecht, and B. B. Loerincz. Eur J Surg Oncol 41, no. 6 (Jun 2015): 773-8.
  49. Two-Year Survival Analysis of 50 Consecutive Head and Neck Cancer Patients Treated with Transoral Robotic Surgery in a Single European Centre. Loerincz, B. B., N. Möckelmann, C. J. Busch, A. Muenscher, S. Sehner, C. V. Dalchow, and R. Knecht. Ann Surg Oncol 22 Suppl 3 (Dec 2015): S1028-33.
  50. Functional Outcomes, Feasibility, and Safety of Resection of Transoral Robotic Surgery: Single-Institution Series of 35 Consecutive Cases of Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma. Loerincz, B. B., N. Möckelmann, C. J. Busch, and R. Knecht. Head Neck 37, no. 11 (Nov 2015): 1618-24.
  51. Molecular Targeting in Combination with Platinum-Based Chemoradiotherapy in Head and Neck Cancer Treatment. Möckelmann, N., M. Kriegs, B. B. Lorincz, C. J. Busch, and R. Knecht. Head Neck (Mar 17 2015).
  52. Feasibility and Safety of Transoral Robotic Surgery (Tors) for Early Hypopharyngeal Cancer: A Subset Analysis of the Hamburg University Tors-Trial. Lorincz, B. B., C. J. Busch, N. Möckelmann, and R. Knecht. Eur Arch Otorhinolaryngol 272, no. 10 (Oct 2015): 2993-8.
  53. Initial Learning Curve of Single-Incision Transaxillary Robotic Hemi- and Total Thyroidectomy–a Single Team Experience from Europe. Lorincz, B. B., C. J. Busch, N. Möckelmann, and R. Knecht. Int J Surg 18 (Jun 2015): 118-22.
  54. Single-Incision Transaxillary Robotic Total Thyroidectomy for Graves‘ Disease: Improved Feasibility and Safety with Novel Robotic Instrumentation. Lorincz, B. B., N. Möckelmann, and R. Knecht. Eur Arch Otorhinolaryngol 271, no. 12 (Dec 2014): 3349-53.
  55. Therapy of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Highlights of the Asco Meeting 2014. Zeller, N., C. J. Busch, P. Schafhausen, R. Knecht, and N. Möckelmann. Hno 62, no. 11 (Nov 2014): 787-92.
  56. Circulating Tumor Cells in Head and Neck Cancer: Clinical Impact in Diagnosis and Follow-Up. Möckelmann, N., S. Laban, K. Pantel, and R. Knecht. Eur Arch Otorhinolaryngol 271, no. 1 (Jan 2014): 15-21.
  57. Current Treatment Options for Recurrent/Metastatic Head and Neck Cancer: A Post-Asco 2011 Update and Review of Last Year’s Literature. Kurzweg, T., N. Möckelmann, S. Laban, and R. Knecht. Eur Arch Otorhinolaryngol 269, no. 10 (Oct 2012): 2157-67.
  58. Investigation of Innate Immunity Genes Card4, Card8 and Card15 as Germline Susceptibility Factors for Colorectal Cancer. Möckelmann, N., W. von Schonfels, S. Buch, O. von Kampen, B. Sipos, J. H. Egberts, P. Rosenstiel, A. Franke, M. Brosch, S. Hinz, C. Roder, H. Kalthoff, U. R. Folsch, M. Krawczak, S. Schreiber, C. D. Broring, J. Tepel, C. Schafmayer, and J. Hampe. BMC Gastroenterol 9 (2009)

Urologie

Prof. Dr. med. Michael Rink, Chefarzt
Zu den Publikationen
Historisches Gebäude mit vielen Fenstern und einem begrünten Vorplatz unter blauem Himmel.

Unsere Kliniken

Jede unserer Kliniken hat besondere Schwerpunkte und ein erfahrenes eingespieltes Team, das sich Zeit für Sie nimmt.

Zu den Kliniken

Das könnte Sie auch interessieren

Moderner, gläserner Anbau an ein historisches Gebäude, beleuchtet bei Nacht.
Über uns

Sie möchten mehr über uns wissen? Hier erhalten Sie Informationen zur Leitung, zu unseren Tochterunternehmen, zum Thema Nachhaltigkeit sowie zu Zahlen und Fakten.

Mehr erfahren